Johnson & Johnson Hit With $29 Million Verdict in Case Over Talc and Asbestos

The company’s stock dipped on Thursday after a California jury found in favor of a woman who claimed that asbestos in the company’s talc-based powders caused her cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *